Balance Sheet Data
Kazia Therapeutics Limited (KZIA)
$0.9952
-0.01 (-1.47%)
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Total Cash | 5.43 | 8.76 | 27.59 | 7.36 | 5.24 | 34,843,747.29 | 166,213,533,993.18 | 792,880,818,741,887.88 | 3,782,243,103,949,726,720 | 1.8,042,261,282,186,712e+22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 1.55 | 1.19 | 0.08 | 0.05 | 0.11 | 475,183.18 | 2,266,744,573.74 | 10,812,947,961,163.93 | 51,580,511,084,091,536 | 246,052,152,775,708,278,784 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.05 | 1.69 | 1.89 | 1.52 | 0.86 | 7,195,975.72 | 34,326,633,842.72 | 163,746,771,348,864.25 | 781,113,733,727,350,272 | 3.726,111,116,521,345e+21 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.